Funding Rounds
Brainvectis Series A round, September 2016
BrainvectisBrainvectis is a biotechnology company developing treatments for neurodegenerative diseases through restoring cholesterol metabolism in the brain.
Summary
Stage: Series A
Raised Amount: $1.20M
Raised Date: 2016-09-01